Maduell Francisco, Escudero-Saiz Victor Joaquin, Cuadrado-Payán Elena, Rodriguez-Garcia Maria, Rodas Lida María, Fontseré Néstor, Salgado Maria Del Carmen, Casals Gregori, Rico Nayra, Broseta José Jesús
Nephrology Department, Hospital Clínic Barcelona, Barcelona, Spain.
Biochemistry and Molecular Genetics Department-CDB, Hospital Clínic Barcelona, Barcelona, Spain.
Clin Kidney J. 2025 May 8;18(5):sfaf146. doi: 10.1093/ckj/sfaf146. eCollection 2025 May.
New cartridges have been developed using the latest resins for hemoadsorption (HA). When used alongside dialyzers, these cartridges may enhance the removal of certain uremic toxins achieved with classical diffusion and convection. This study aimed to assess the elimination of a wide range of molecular weight solutes, including protein-bound uremic toxins, in hemodialysis (HD) and postdilution hemodiafiltration (HDF) treatments.
A prospective study was conducted involving 20 patients who underwent six dialysis sessions with routine treatment parameters maintenance, while only the dialysis modality was modified. The modalities included low-flux HD (LFHD), LFHD-HA, high-flux HD (HFHD), HFHD-HA, HDF and HDF-HA.
Urea and creatinine reduction ratios (RR) were higher in HDF treatments (with or without HA) versus LFHD and HFHD treatments. In the same treatment modality, the addition of HA did not modify the small molecules removal. The combination of LFHD-HA showed increased RR of β-microglobulin, myoglobin, prolactin and lambda-free immunoglobulin light chains (λFLC) compared with HD alone. Similarly, the combination of HFHD-HA showed increased RR of myoglobin, α-microglobulin and λFLC compared with HFHD alone. However, in terms of HDF, the addition of HA tended to slightly increase RR, but only those of β-microglobulin were significant. Overall, HDF both with and without HA was clearly superior to LFHD and HFHD treatments. Moreover, regardless of the addition of HA, HFHD was superior to LFHD treatments.
The results confirmed the superiority of postdilution HDF over LFHD and HFHD, as well as HFHD over LFHD. Incorporating adsorption into the standard LFHD diffusion significantly enhanced the removal of uremic toxins, whose clearance is restricted by the dialyzer's pore size. In contrast, incorporating adsorption alongside the typical diffusion and convection resulted in a modest enhancement in HFHD, with similar outcomes for HDF.
已经研发出使用最新树脂用于血液吸附(HA)的新型滤器。当与透析器一起使用时,这些滤器可能会增强通过传统扩散和对流实现的某些尿毒症毒素的清除。本研究旨在评估在血液透析(HD)和后稀释血液透析滤过(HDF)治疗中多种分子量溶质的清除情况,包括与蛋白质结合的尿毒症毒素。
进行了一项前瞻性研究,纳入20例患者,他们接受了6次透析治疗,维持常规治疗参数不变,仅改变透析方式。这些方式包括低通量HD(LFHD)、LFHD-HA、高通量HD(HFHD)、HFHD-HA、HDF和HDF-HA。
与LFHD和HFHD治疗相比,HDF治疗(无论有无HA)的尿素和肌酐清除率(RR)更高。在相同的治疗方式中,添加HA并未改变小分子的清除。与单纯HD相比,LFHD-HA联合使用时β-微球蛋白、肌红蛋白、催乳素和λ-游离免疫球蛋白轻链(λFLC)的RR增加。同样,与单纯HFHD相比,HFHD-HA联合使用时肌红蛋白、α-微球蛋白和λFLC的RR增加。然而,就HDF而言,添加HA倾向于使RR略有增加,但仅β-微球蛋白的增加具有统计学意义。总体而言,有HA和无HA的HDF均明显优于LFHD和HFHD治疗。此外,无论是否添加HA,HFHD均优于LFHD治疗。
结果证实了后稀释HDF优于LFHD和HFHD,以及HFHD优于LFHD。将吸附纳入标准的LFHD扩散中可显著增强尿毒症毒素的清除,这些毒素的清除受透析器孔径限制。相比之下,在典型的扩散和对流基础上加入吸附,HFHD的清除增强幅度较小,HDF的结果相似。